BioSpace News Archive

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Brian Mueller , Executive Vice President, Chief Financial Officer, will participate in Morningstar’s Management Behind the Moat Conference on Septem

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced it will host a virtual Key Opinion Leader (KOL) event on the perioperative use of DSUVIA, on Wednesday

A total of 6 products from the Lorient product line of cross-linked hyaluronic acid dermal fillers developed by Joonghun Pharmaceutical (CEO Sukjoon Yoon) have received the CE mark. Lorient is a premium cross-linked hyaluronic dermal filler that has established a foothold for entry into the European beauty market by proving the safety and quality suitable for global standards through the acquisition of this European certification. Lorie

A panel of eight distinguished leaders in Life Sciences came together for a virtual breakfast roundtable devoted to leading Life Sciences organizations through these unprecedented times.

Additional education and training sets orthodontists apart from general dentists when it comes to treatment expertise and understanding of tooth movement.

FUJIFILM Irvine Scientific, Inc., today announced that it has become the exclusive, worldwide distributor of cellnest ® , a recombinant peptide attachment substrate that provides optimal adhesion and proliferation of stem cells in chemically defined, animal component-free conditions. Cellnest was desig

The pandemic has upended the lives and wellbeing of nearly everyone, but Healthcare employees had the largest decrease in motivation of any industry and were least likely to say their employer was supportive, according to a new meQuilibrium study of 7,000 workers which compared changes in job stress, burnout, motivation and sleep between December 2019 and June 2020.

ProciseDx Inc. has established distribution agreements with two new distributors in Europe: BHR Pharmaceuticals Ltd in the United Kingdom and D.I.D Diagnostic International Distribution S.p.A. in Italy.

ITM Medical Isotopes GmbH, a subsidiary of the biotechnology and radiopharmaceutical group of companies ITM Isotopen Technologien München AG (ITM), Bruce Power, an electricity company, and IsoGen, a joint venture between the two nuclear energy companies Framatome and Kinectrics, announced today that Bruce Power and IsoGen have set the first critical milestone for a reliable and consistent irradiation service which will be provided to ITM exclusively for 15 years

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has filed a provisional patent for a first-in-class face mask that captures and deactivates SARS-CoV-2, the coronavirus responsible for the ongoing COVID-19 pandemic.